| Product NDC: | 0703-1501 |
| Proprietary Name: | Alprostadil |
| Non Proprietary Name: | Alprostadil |
| Active Ingredient(s): | 500 ug/mL & nbsp; Alprostadil |
| Administration Route(s): | INTRAVASCULAR |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0703-1501 |
| Labeler Name: | Teva Parenteral Medicines, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075196 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19990430 |
| Package NDC: | 0703-1501-02 |
| Package Description: | 5 VIAL in 1 TRAY (0703-1501-02) > 1 mL in 1 VIAL (0703-1501-01) |
| NDC Code | 0703-1501-02 |
| Proprietary Name | Alprostadil |
| Package Description | 5 VIAL in 1 TRAY (0703-1501-02) > 1 mL in 1 VIAL (0703-1501-01) |
| Product NDC | 0703-1501 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Alprostadil |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVASCULAR |
| Start Marketing Date | 19990430 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc |
| Substance Name | ALPROSTADIL |
| Strength Number | 500 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE] |